Eurofins Scient (OTCMKTS:ERFSF) Shares Down 7% – Here’s Why

Eurofins Scient (OTCMKTS:ERFSFGet Free Report)’s stock price fell 7% during trading on Wednesday . The stock traded as low as $74.32 and last traded at $74.32. 517 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 6,192 shares. The stock had previously closed at $79.9150.

Wall Street Analyst Weigh In

Several research firms have commented on ERFSF. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

View Our Latest Analysis on Eurofins Scient

Eurofins Scient Trading Up 2.0%

The company has a 50 day simple moving average of $76.78 and a 200 day simple moving average of $74.59.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

See Also

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.